About Alsachim
Alsachim is a company based in Illkirch-graffenstaden (France) founded in 2005 by Jean-Francois Hoeffler was acquired by Shimadzu Corporation in June 2017. Alsachim offers products and services including Stable Labeled Standards, Reference Standards, Reagent Kits, and Custom Synthesis. Alsachim operates in a competitive market with competitors including ARTMS, NorthStar Medical Radioisotopes, Niowave, Ground Fluor Pharmaceuticals and AZI, among others.
- Headquarter Illkirch-graffenstaden, France
- Founders Jean-Francois Hoeffler
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Shimadzu Corporation
& 1 more
-
Employee Count
Not available
-
Acquired by
Shimadzu Corporation
(Jun 21, 2017)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Alsachim
Alsachim offers a comprehensive portfolio of products and services, including Stable Labeled Standards, Reference Standards, Reagent Kits, and Custom Synthesis.
Standards for precise laboratory analysis and testing
Products for accurate chemical reference in diagnostics
Kits like DOSIMMUNE for specific clinical applications
Tailored synthesis services for research needs
Funding Insights of Alsachim
Investors in Alsachim
Alsachim has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Shimadzu Corporation and Naxicap.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments in small and medium-sized businesses are managed by Naxicap.
|
Locked | Locked | Locked | |
|
Medical imaging systems, industrial machinery, and analytical instruments are provided.
|
Locked | Locked | Locked |
Investor details for Alsachim
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Alsachim
Investment portfolio details for Alsachim
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Alsachim
Detailed financials for Alsachim
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Alsachim Comparisons
Peer comparison for Alsachim
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Alsachim
Alsachim operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ARTMS, NorthStar Medical Radioisotopes, Niowave, Ground Fluor Pharmaceuticals and AZI, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Radioisotope technologies and services are developed and provided by ARTMS.
|
|
| Locked | Locked | Locked |
Provider of sourcing, purification, and separation technologies for the Nuclear Medicine market
|
|
| Locked | Locked | Locked |
Devices and radioisotopes for nuclear imaging are provided by Niowave.
|
|
| Locked | Locked | Locked |
Proprietary chemistry for pharmaceutical synthesis is developed by the company.
|
|
| Locked | Locked | Locked |
Radiopharmaceuticals for diagnostic imaging are developed and produced.
|
|
| Locked | Locked | Locked |
Multimodal visualization agents are developed for image-guided interventions.
|
Detailed competitors of Alsachim
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Alsachim
Complete news archive for Alsachim
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Alsachim
Alsachim was founded in 2005 and raised its 1st funding round 1 year after it was founded.
Alsachim is headquartered in Illkirch-graffenstaden, France. It is registered at Illkirch-graffenstaden, Bas-rhin, France.
Jean-Francois Hoeffler is the current CEO of Alsachim. They have also founded this company.
Alsachim was founded in 2005 and is based in Illkirch Graffenstaden, France. Operations focus on the pharmaceutical and biotechnology industries, where custom synthesis of stable isotopically labeled molecules is conducted, including intermediates, reference standards, metabolites, peptides, and biologically active compounds. Analytical services, such as HPLC, mass spectrometry, and NMR analysis, are also offered to support research and development needs in these sectors.
Alsachim's top competitors include ARTMS, NorthStar Medical Radioisotopes and Niowave.
Alsachim offers Stable Labeled Standards, Reference Standards, Reagent Kits, and Custom Synthesis.
Alsachim has 2 investors. Key investors include Shimadzu Corporation, and Naxicap.